Dianthus Therapeutics, Inc. /DE/
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $2.0 | $6.2 | $2.8 | — | — |
| Operating income | -$177.9 | -$101.9 | -$48.2 | -$29.7 | -$74.7 |
| Net income | -$162.3 | -$85.0 | -$43.6 | -$28.5 | -$71.1 |
| Cash Flow Statement | |||||
| Free cash flow | — | — | — | -$29.4 | -$60.8 |
Shares outstanding 55.9M · Free float 67.7%
Annual filing data through FY ended December 31, 2025; float as of October 3, 2026.